AMGN
55
-2
JCI
44
2
KIM
51
4
UHS
60
-3
FSLR
76
3
GS
69
-3
XYL
60
-2
CVS
43
2
IP
62
-2
BK
74
3
SYF
83
2
TSN
38
-2
PEG
55
2
BIIB
45
-3
RSG
67
2
PYPL
31
2
CMG
70
-2
CHD
62
-2
BMY
35
2
SRE
61
14
AMGN
55
-2
JCI
44
2
KIM
51
4
UHS
60
-3
FSLR
76
3
GS
69
-3
XYL
60
-2
CVS
43
2
IP
62
-2
BK
74
3
SYF
83
2
TSN
38
-2
PEG
55
2
BIIB
45
-3
RSG
67
2
PYPL
31
2
CMG
70
-2
CHD
62
-2
BMY
35
2
SRE
61
14
Financhill
Back

Raffles Medical Group Vs. CytoMed Therapeutics Industry Stock Comparison

Sell
30

RAFLF
Raffles Medical Group

Last Price:
0.74
Seasonality Move:
2.11%
Sell
22

GDTC
CytoMed Therapeutics

Last Price:
2.11
Seasonality Move:
34.81%
Sell
30
Raffles Medical Group (RAFLF) is a Sell

Is Raffles Medical Group a Buy, Sell or Hold?

  • The current Raffles Medical Group [RAFLF] share price is $0.74. The Score for RAFLF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RAFLF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
CytoMed Therapeutics (GDTC) is a Sell

Is CytoMed Therapeutics a Buy, Sell or Hold?

  • The current CytoMed Therapeutics [GDTC] share price is $2.12. The Score for GDTC is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • GDTC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RAFLF Stock Price Chart

What is Raffles Medical Group's stock price today?

  • The Raffles Medical Group share price today is $0.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RAFLF is experiencing slight buying pressure.

GDTC Stock Price Chart

What is CytoMed Therapeutics's stock price today?

  • The CytoMed Therapeutics share price today is $2.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing selling pressure, which indicates risk of future bearish movement.

RAFLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 17.39 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.74 - 0.74) Sell
Bollinger Bands (100): (0.72 - 0.76) Sell

GDTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 48.89 Sell
Chaikin Money Flow: -5302 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.07 - 2.19) Sell
Bollinger Bands (100): (1.81 - 3.65) Sell

RAFLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.74 Sell
20-day SMA: 0.74 Sell
50-day SMA: 0.74 Sell
200-day SMA: 0.85 Sell
8-day EMA: 0.74 Sell
20-day EMA: 0.74 Sell
50-day EMA: 0.74 Sell
200-day EMA: 0.82 Sell

GDTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.14 Sell
20-day SMA: 2.14 Sell
50-day SMA: 2.14 Sell
200-day SMA: 3.2 Sell
8-day EMA: 2.14 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.24 Sell
200-day EMA: 2.88 Sell

Raffles Medical Group Earnings Growth & RAFLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CytoMed Therapeutics Earnings Growth & GDTC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and a decrease next year of $0.00 per share.

Raffles Medical Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CytoMed Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):